IKSInventurus Knowledge Solutions Ltd.
Inventurus Knowledge Solutions merges US unit Turbo Health into IKS Inc.
- Mergers & acquisitions
- healthcare technology services
Inventurus Knowledge Solutions (NSE: IKS) has approved a merger of its step-down subsidiary Turbo Health Holdings, LLC into Inventurus Knowledge Solutions, Inc., a wholly owned material subsidiary, it said in a filing on 19 Nov 2026. The merger involves no cash consideration and no new shares.
Key highlights
- Consideration: nil, no cash or new shares involved
- Turbo Health incorporated on 5 Nov 2026 and bought by IKS Inc. on 10 Nov 2026
- IKS Inc. FY 2025-26 total income: ₹1,474.14 crore
- Shareholding of the company: unchanged
The merger in numbers
| Item | Detail |
|---|---|
| Entities | Turbo Health Holdings, LLC (transferor) into Inventurus Knowledge Solutions, Inc. (transferee) |
| Board approval | IKS Inc. board, subject to applicable laws in the United States |
| Cash consideration | Nil; no new shares issued |
| IKS Inc. FY 2025-26 revenue from operations | ₹1,458.77 crore |
| IKS Inc. FY 2025-26 other income | ₹15.37 crore |
| IKS Inc. FY 2025-26 total income | ₹1,474.14 crore |
| Related party transaction | Yes; the company states the merger will be at arm's length |
| Information received by the company | 19 Nov 2026 at 10:03 PM IST |
What the merger does
The filing says the board of IKS Inc. has approved merging Turbo Health, a US company wholly owned by IKS Inc., into IKS Inc. Turbo Health holds contracts for ambulatory revenue cycle management (RCM) services and was incorporated on 5 Nov 2026. IKS Inc. bought it on 10 Nov 2026.
On completion, the entire share capital of Turbo Health will be cancelled. The company says there will be no cash consideration or issuance of new shares, because Turbo Health is wholly owned by IKS Inc.
Rationale and scale
The company's stated reason is to streamline the corporate structure. It says that, given Turbo Health's compact scale, keeping a separate legal entity is commercially unwarranted, and that merging with the main US entity enables operational consolidation.
IKS Inc. reported FY 2025-26 total income of ₹1,474.14 crore, from revenue from operations of ₹1,458.77 crore and other income of ₹15.37 crore. Turbo Health's own figures are not given in the filing.
What the merger means for Inventurus Knowledge Solutions' shareholders
The company's shareholding is unchanged, since the merger is between two of its foreign subsidiaries and involves no share issue. The merger is subject to US laws, and the company says it will be at arm's length. The filing does not say what the deal's effect on the company's financial results will be, when the merger becomes effective, or what consideration was paid for Turbo Health beyond its purchase on 10 Nov 2026.
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Get the Blacklitt app
Hold Inventurus Knowledge Solutions Ltd.? See it with the rest of your portfolio
Bring in your stocks and mutual funds once. Blacklitt sets them against a plan for your goals and risk, and tells you what to change and why.
Fee-only SEBI Registered Investment Adviser, INA000022428. No commission from any fund house, broker or company.
Scan with your phone camera to get the app.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
